Vesalius-CV

Vesalius-CV

The purpose of this study is to assess the effect of lowering LDL-C with Evolocumab on major cardiovascular events in patients without a prior MI or stroke who are at high risk of a cardiovascular event.

Please use this link for further information:

Primary Investigator: Dean Kereiakes

Follow up only

Disclaimer: Patients must have an existing, documented diagnosis to be entered into some trials.
Copyright © 2024 All rights reserved.

Web Design by TBH Creative